2023
Transmission-blocking activity of antimalarials for Plasmodium vivax malaria in Anopheles darlingi
Andrade A, Santos N, Bastos A, Pontual J, Araújo J, Silva A, Martinez L, Lima A, Aguiar A, Teles C, Medeiros J, Pereira D, Vinetz J, Gazzinelli R, Araújo M. Transmission-blocking activity of antimalarials for Plasmodium vivax malaria in Anopheles darlingi. PLOS Neglected Tropical Diseases 2023, 17: e0011425. PMID: 37327209, PMCID: PMC10310017, DOI: 10.1371/journal.pntd.0011425.Peer-Reviewed Original ResearchConceptsDensity of gametocytesTransmission-blocking efficacyPlasmodium vivax malariaTransmission-blocking activityImportant infectious diseasesOne-doseVivax malariaP. vivaxMosquito infectionPlasmodium vivaxTreatment groupsPatient's bloodGametocyte productionMalaria transmissionInfectious diseasesGenus PlasmodiumMalariaTreatmentChloroquinePrimaquineVivaxBloodDirect membraneBiological characteristicsMosquitoes
2005
A global research agenda for leptospirosis.
Cachay E, Vinetz J. A global research agenda for leptospirosis. Journal Of Postgraduate Medicine 2005, 51: 174-8. PMID: 16333188, PMCID: PMC2270399.Peer-Reviewed Original ResearchConceptsImpact of leptospirosisVaccine-induced protective immunityEffective adjunct treatmentPublic health effortsAdjunct treatmentProtective immunityClinical leptospirosisHealth research fundingHealth effortsLeptospirosis pathogenesisAppropriate mobilizationSpirochetal diseasesLeptospirosisLeptospirosis transmissionCollaborative international effortDiseaseMammalian reservoirsTreatmentHealthVeterinary healthMorbidityRural areasPathogenesisGlobal research agendaMortality